Skip to content

Maxim® Knee Pop-Top® Tibia vs. Regular Maxim® Knee Tibia

A Randomized Data Collection of the Maxim® Knee System With Removable Molded Polyethylene Tibia and the Regular Maxim® Knee System

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00579059
Enrollment
31
Registered
2007-12-21
Start date
2004-05-31
Completion date
2007-11-30
Last updated
2017-07-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis, Rheumatoid Arthritis, Traumatic Arthritis

Brief summary

The purpose of this prospective clinical data collection is to compare the outcomes of two different tibial bearings: the Maxim® Pop-Top® Tibia and Maxim® Modular Tibia.

Detailed description

The purpose of this prospective clinical data collection is to document and compare the performance and clinical outcomes between the Maxim® Knee System with Removable Molded Poly Tibia and the Maxim® Knee System with Modular Tibial Bearing as two treatment groups. FDA has cleared these devices via Premarket Notification 510(k)'s K991753, K984623, K993159, K010027. The data gathered will be collated and used to provide feedback to designing engineers, support marketing efforts and answer potential questions from reimbursement agencies.

Interventions

DEVICEMaxim® Knee System with Removable Molded Polyethylene Tibia

Used for total knee replacements

DEVICERegular Maxim® Knee System

Used for total knee replacements

Sponsors

Biomet Orthopedics, LLC
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Identical to the indications stated in the FDA approved labeling for the device (cleared in 510(k) K991753, K984623, K993159, K010027). These indications are stated below: * Painful and disabled knee joint resulting from osteoarthritis, rheumatoid arthritis, traumatic arthritis where one or more compartments are involved. * Correction of varus, valgus, or posttraumatic deformity. * Correction or revision of unsuccessful osteotomy, arthrodesis, or failure of previous joint replacement procedure. Patient selection factors to be considered include: * need to obtain pain relief and improve function, * ability and willingness of the patient to follow instructions, including control of weight and activity level, * a good nutritional state of the patient, * the patient must have reached full skeletal maturity. * Porous coated knee joint replacement prostheses have not been approved for non-cemented applications in the United States.

Exclusion criteria

Identical to the contraindications stated in the FDA approved labeling for the device (cleared in 510(k) K991753, K984623, K993159, K010027's). These contraindications are stated below: Absolute contraindications include: * infection, * sepsis * osteomyelitis. Relative contraindications include: * uncooperative patient or patient with neurologic disorders who are incapable of following directions, * Osteoporosis, * metabolic disorders which may impair bone formation, * osteomalacia, * distant foci of infections which may spread to the implant site, * rapid joint destruction, marked bone loss or bone resorption apparent on roentgenogram, * vascular insufficiency, muscular atrophy, neuromuscular disease, * incomplete or deficient soft tissue surrounding the knee.

Design outcomes

Primary

MeasureTime frameDescription
Knee Society Function Score1 YearThe function score is detailed below as a Range; 100 being the highest score, and 0 being the lowest score. 90-100 is considered Excellent, 60-89 is considered Good, 30-59 is considered fair, and 0-29 is considered poor.

Secondary

MeasureTime frameDescription
Range of Motion - Flexion1 YearThis represents how far the patients were able to flex the knee in the clinic at 1-year.

Countries

United States

Participant flow

Recruitment details

Patients were recruited by the investigator.

Pre-assignment details

There were no pre-assignment details to report.

Participants by arm

ArmCount
Maxim® Pop-Top® Tibia
tibia with removable polyethylene
21
Maxim® Regular Tibia
Tibia with Modular Polyethylene
10
Total31

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyStudy Canceled at 1 Year2110

Baseline characteristics

CharacteristicMaxim® Pop-Top® TibiaMaxim® Regular TibiaTotal
Age, Continuous68 years
FULL_RANGE 8
62 years
FULL_RANGE 6
65 years
Region of Enrollment
United States
21 participants10 participants31.0 participants
Sex: Female, Male
Female
17 Participants5 Participants22 Participants
Sex: Female, Male
Male
4 Participants5 Participants9 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 210 / 10
serious
Total, serious adverse events
0 / 210 / 10

Outcome results

Primary

Knee Society Function Score

The function score is detailed below as a Range; 100 being the highest score, and 0 being the lowest score. 90-100 is considered Excellent, 60-89 is considered Good, 30-59 is considered fair, and 0-29 is considered poor.

Time frame: 1 Year

Population: This population represents patients that returned for follow-up at 1-year post-op per protocol.

ArmMeasureGroupValue (NUMBER)
Maxim® Pop-Top® TibiaKnee Society Function Score90-1006 knees
Maxim® Pop-Top® TibiaKnee Society Function Score60-892 knees
Maxim® Pop-Top® TibiaKnee Society Function Score30-590 knees
Maxim® Pop-Top® TibiaKnee Society Function Score0-290 knees
Maxim® Regular TibiaKnee Society Function Score0-290 knees
Maxim® Regular TibiaKnee Society Function Score90-1002 knees
Maxim® Regular TibiaKnee Society Function Score30-590 knees
Maxim® Regular TibiaKnee Society Function Score60-891 knees
Secondary

Range of Motion - Flexion

This represents how far the patients were able to flex the knee in the clinic at 1-year.

Time frame: 1 Year

Population: This population represents patients that returned for follow-up at 1-year post-op per protocol.

ArmMeasureValue (MEAN)
Maxim® Pop-Top® TibiaRange of Motion - Flexion118 degrees
Maxim® Regular TibiaRange of Motion - Flexion113 degrees

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026